Delivery Order SPE2DB24D1104-SPE2DB24FYBX0

Award Date 8/20/24
Potential Completion Date 9/11/24
Potential Value $4.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of NUBEQA 300 MG TABLET 120S, a pharmaceutical product, with a completion date of September 26, 2024. The contract is a Delivery Order under a Firm Fixed Price (FFP) arrangement. There is no set-aside designation indicated for this award. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is a delivery order for the pharmaceutical product NUBEQA 300 MG TABLET 120S, with a completion date of November 1, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and indefinite delivery contracts (IDCs) by the DLA and other agencies to supply a wide range of...
This federal contract award, with ID SPE2DB22D2007|SPE2DB24FJ5DR, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The $4,683.97 firm fixed price delivery order is for the supply of NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by the DLA and other agencies to...
This federal contract award, valued at $21,110.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4564287851 NUBEQA 300 MG TABLET 120S, a prescription pharmaceutical product. The award is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, through its Corporate Office division, a delivery order contract valued at $3,518.40 for the supply of NUBEQA 300 MG TABLET 120S. This order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,641.98, is for the delivery of 4567624643 ! NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 9, 2025. The contract was awarded on March 19, 2025 and does not have a set-aside...
This federal contract award to Amerisourcebergen Drug Corp is a delivery order (SPE2DB24D1205|SPE2DB25FCWMP) from the Defense Logistics Agency (DLA), a defense agency, for the supply of 4,568,155,984 units of the pharmaceutical product NUBEQA 300 MG TABLET 120S. The contract has a firm fixed price of $7,641.98 and a completion date of May 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set aside. The company also holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,691.72 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a comprehensive vehicle for providing...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,683.97 firm fixed-price delivery order is for the supply of NUBEQA 300 MG tablets, a prescription medication. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The $7,641.98 firm fixed-price delivery order is for NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of June 27, 2025. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a...
  • SPE2DB24D1104
    Indefinite Delivery Contract
  • SPE2DB24D1104-SPE2DB24FYBX0
    Delivery Order

This federal contract award, valued at $4,683.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of 4565519528 - NUBEQA 300 MG TABLET 120S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of September 11, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to various government agencies and healthcare programs, including the military treatment facilities and veterans' hospitals served by the DLA.

Generated 11/19/24, 9:26 AM